Welcome to the ValueWiki Gentium SpA (GENT) article! Register for free or click the "edit" link to contribute!    

Gentium SpA (GENT)

From ValueWiki

Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about Gentium SpA? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max





Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.[1] Be bold!

News Feed

11/19/08 4:11 pm Gentium Provides an Update on the Phase 3 Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease (Business Wire)
10/02/08 6:10 am Gentium Announces that Italian Court Rejects Plaintiffs' Claims and Ends Legal Proceeding (Business Wire)
08/26/08 3:08 pm Gentium Announces Italian Legal Proceeding (Business Wire)
04/22/08 8:04 am GENTIUM S.P.A. Financials (EDGAR Online Financials)
01/24/08 3:01 pm Thursday's Health Winners & Losers (at TheStreet.com)
More News...

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

Gentium SpA Snapshot
Gentium SpA Leadership
Gentium SpA Fundamentals
Gentium SpA Technical Analysis
Gentium SpA Message Boards

Notes

  1. This is a sample reference.
Personal tools